Infections in Systemic Connective Tissue Diseases: Systemic Lupus Erythematosus, Scleroderma, and Polymyositis/Dermatomyositis

Infectious Disease Clinics of North America

Volumn 20, Issue 4, 2006, Pages 849-875

  Alarcón, Graciela S ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ACTINOMYCOSIS; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BACTERIAL SKIN DISEASE; CATHETER INFECTION; CAUSE OF DEATH; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG MEGADOSE; GENETIC PREDISPOSITION; GRAM NEGATIVE INFECTION; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFECTION SENSITIVITY; LEUKOPENIA; LISTERIOSIS; LUNG TUBERCULOSIS; MYCOBACTERIOSIS; MYCOSIS; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NOCARDIOSIS; OPPORTUNISTIC INFECTION; PARASITOSIS; PARVOVIRUS INFECTION; PERITONEAL DIALYSIS; PLASMAPHERESIS; POLYMYOSITIS; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; SALMONELLOSIS; SCLERODERMA; SEPSIS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STRONGYLOIDIASIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION; VISCERAL LEISHMANIASIS;

EID: 33751105227     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2006.09.007     Document Type: Review

References (175)

1. Juárez M., Misischia R., and Alarcón G.S. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin North Am 29 (2003) 163-184
2. Alarcón G.S., McGwin Jr. G., Bastian H.M., et al. Systemic lupus erythematosus in three ethnic group VII: predictors of early mortality in the LUMINA cohort. Arthritis Rheum 45 (2001) 191-202 [Arthritis Care Res]
3. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine 78 (1999) 167-175
4. Fessler B.J. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16 (2002) 281-291
5. Gladman D.D., Hussian F., Ibanez D., et al. The nature and outcome of infection in systemic lupus erythematosus. Lupus 11 (2002) 234-239
6. Hesselstrand R., Scheja A., and Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57 (1998) 682-686
7. Koler R.A., and Motemarano A. Dermatomyositis. Am Fam Physician 64 (2001) 1565-1572
8. Marie I., Hachulla E., Hatron P.Y., et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28 (2001) 2230-2237
9. Massardo L., Martinez M.E., Baro M., et al. Infections in systemic lupus erythematosus. [Infecciones en lupus eritematoso sistémico]. Rev Med Chil 119 (1991) 1115-1122
10. Nived O., Sturfelt G., and Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. QJM 55 (1985) 271-287
11. Noel V., Lortholary O., Casassus P., et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60 (2001) 1141-1144
12. Paton N.I., Cheong I.K., Kong N.C., et al. Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 89 (1996) 531-538
13. Petri M., and Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins lupus cohort. J Rheumatol 19 (1992) 1559-1565
14. Prakash U.B.S. Thoracic manifestations of the systemic autoimmune diseases. Respiratory complications in mixed connective tissue disease. Clin Chest Med 19 (1998) 733-746
15. Rahman P., Gladman D.D., Urowitz M.B., et al. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 10 (2001) 93-96
16. Ward M.M., Pyun E., and Studenski S. Causes of death in systemic lupus erythematosus: long-term followup of an inception cohort. Arthritis Rheum 38 (1995) 1492-1499
17. Zonana-Nacach A., Camargo-Coronel A., Yañez P., et al. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10 (2001) 505-510
18. de Luis A., Pigrau C., Pahissa A., et al. Infections in 96 cases of systemic lupus erythematosus. [Infecciones en 96 casos de lupus eritematoso sistémico]. Med Clin (Barc) 94 (1990) 607-610
19. Hellmann D.B., Petri M., and Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine 66 (1987) 341-348
20. Iriya S.M., Capelozzi V.L., Calich I., et al. Causes of death in patients with systemic lupus erythematosus in Sao Paulo, Brazil: a study of 113 autopsies. Arch Intern Med 161 (2001) 1557-1561
21. Opastirakul S., and Chartapisak W. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. Pediatr Nephrol 20 (2005) 1750-1755
22. Bernatsky S., Boivin J.F., Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 54 (2006) 2550-2557
23. Chen Y.S., Yang Y.H., Lin Y.T., et al. Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up. Clin Rheumatol 23 (2004) 235-238
24. Zandman-Goddard G., and Shoenfeld Y. Infections and SLE. Autoimmunity 38 (2005) 473-485
25. Le Moing V., and Leport C. Infections et lupus (Infections and lupus). Rev Prat 48 (1998) 637-642
26. Oh H.M., Chng H.H., Boey M.L., et al. Infections in systemic lupus erythematosus. Singapore Med J 34 (1993) 406-408
27. Hidalgo-Tenorio C., Jimenez-Alonso J., de Dios L.J., et al. Urinary tract infections and lupus erythematosus. Ann Rheum Dis 63 (2004) 431-437
28. Sayarlioglu M., Inanc M., Kamali S., et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13 (2004) 274-278
29. Ginzler E., Diamond H., Kaplan D., et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21 (1978) 37-44
30. Garcia C., Ugalde E., Campo A.B., et al. Fatal case of community-acquired pneumonia caused by Legionella longbeachae in a patient with systemic lupus erythematosus. Eur J Clin Microbiol Infect Dis 23 (2004) 116-118
31. Hung J.J., Ou L.S., Lee W.I., et al. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32 (2005) 40-43
32. Kiertiburanakul S., Wirojtananugoon S., Pracharktam R., et al. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 10 (2006) 72-78
33. Ross S.C., and Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 63 (1984) 243-273
34. Mitchell S.R., Nguyen P.Q., and Katz P. Increased risk of neisserial infections in systemic lupus erythematosus. Sem Arthritis Rheum 20 (1990) 174-184
35. Garred P., Madsen H.O., Halberg P., et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 42 (1999) 2145-2152
36. Garred P., Voss A., Madsen H.O., et al. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2 (2001) 442-450
37. Bouza E., Moya J.G.-L., and Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 15 (2001) 335-361
38. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 24 (1998) 423-456
39. Wilson J.G., Ratnoff W.D., Schur P.H., et al. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum 29 (1986) 739-747
40. Kim W.U., Min J.K., Lee S.H., et al. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 17 (1999) 539-545
41. Hsieh S.C., Tsai C.Y., Sun K.H., et al. Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Clin Exp Rheumatol 12 (1994) 627-633
42. Boros P., Muryoi T., Spiera H., et al. Autoantibodies directed against different classes of Fc gamma R are found in sera of autoimmune patients. J Immunol 150 (1993) 2018-2024
43. Bermas B.L., Petri M., Goldman D., et al. T helper cell dysfunction in systemic lupus erythematosus (SLE). Relation to disease activity. J Clin Immunol 14 (1994) 169-177
44. Boumpas D.T., Chrousos G.P., Wilder R.L., et al. Glucocorticoid therapy for immune-mediated disease: Basic and clinical correlates. Ann Intern Med 119 (1993) 1198-1208
45. Cunha B.A. Infections in nonleukopenic compromised hosts (diabetes mellitus, SLE, steroids, and asplenia) in critical care. Crit Care Clin 14 (1998) 264-282
46. Hrycek A., Kusmierz D., Mazurek U., et al. Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity 38 (2005) 487-491
47. Kang I., Quan T., Nolasco H., et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172 (2004) 1287-1294
48. Huhn R., Schmeling H., Kunze C., et al. Pneumococcal sepsis after autosplenectomy in a girl with systemic lupus erythematosus. Rheumatology (Oxford) 44 (2005) 1586-1588
49. Duffy K.N., Duffy C.M., and Gladman D.D. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 18 (1991) 1180-1184
50. Iliopoulos A.G., and Tsokos G.C. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 25 (1996) 318-336
51. Suh C.-H., Jeong Y.-S., Park H.-C., et al. Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Expr Rheumatol 19 (2001) 191-194
52. Wu K.C., Yao T.C., Yeh K.W., et al. Osteomyelitis in patients with systemic lupus erythematosus. J Rheumatol 31 (2004) 1340-1343
53. Al-Mayouf S.M., Al-Jumaah S., Bahabri S., et al. Infections associated with juvenile systemic lupus erythematosus. Clin Exp Rheumatol 19 (2001) 748-750
54. Ng W.L., Chu C.M., Wu A.K., et al. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM 99 (2006) 37-47
55. Galindo M., Mateo I., and Pablos J.L. Multiple avascular necrosis of bone and polyarticular septic arthritis in patients with systemic lupus erythematosus. Rheumatol Int 25 (2005) 72-76
56. Auphan N., DiDonato J.A., Rosette C., et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
57. Ortmann R.A., and Klippel J.H. Update on cyclophosphamide for systemic lupus erythematosus. Rheum Dis Clin North Am 26 (2000) 363-375
58. Pryor B.D., Bologna S.G., and Kahl L.E. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 1475-1482
59. Ginzler E.M., Dooley M.A., Aranow C., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 (2005) 2219-2228
60. Contreras G., Pardo V., Leclercq B., et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 350 (2004) 971-980
61. Ong L.M., Hooi L.S., Lim T.O., et al. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 10 (2005) 504-510
62. Aringer M., Smolen J.S., and Graninger W.B. Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum 41 (1998) 414-420
63. Huang J.W., Hung K.Y., Yen C.J., et al. Systemic lupus erythematosus and peritoneal dialysis: outcomes and infectious complications. Peritoneal Dial Internl 21 (2001) 143-147
64. Traynor A.E., Schroeder J., Rosa R.M., et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356 (2000) 701-707
65. Bellomio V., Spindler A., Lucero E., et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 9 (2000) 377-381
66. Harris E.N., Williams E., Shah D.J., et al. Mortality of Jamaican patients with systemic lupus erythematosus. Br J Rheumatol 28 (1989) 113-117
67. Hernández-Cruz B., Tapia N., Villa-Romero A.R., et al. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol 19 (2001) 395-401
68. Huicochea Grobet Z.L., Berron R., Ortega Martell J.A., et al. Survival up to 5 and 10 years of Mexican pediatric patients with systemic lupus erythematosus. Overhaul of 23 years experience. Allergol Immunopathol (Madr) 24 (1996) 36-38
69. Jindal B., Joshi K., Radotra B.D., et al. Fatal complications of systemic lupus erythematosus-An autopsy study from North India. Indian J Pathol Microbiol 43 (2000) 311-317
70. Mok C.C., Lee K.W., Ho C.T., et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatol 39 (2000) 399-406
71. Rodríguez V.E., and González-Parés E.N. Mortality study in Puerto Ricans with systemic lupus erythematosus. PRHSJ 19 (2000) 335-339
72. Shyam C., and Malaviya A.N. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int 16 (1996) 1-3
73. Jacobsen S., Halberg P., and Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). BJR 37 (1998) 750-755
74. Rosner S., Ginzler E.M., Diamond H.S., et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25 (1982) 612-617
75. La Spina M., and Russo G. Pneumococcal sepsis in a girl with systemic lupus erythematosus. Br J Haematol 122 (2003) 172
76. Chiu W.J., Kao H.T., and Huang J.L. Necrotizing pneumonia caused by Streptococcus pneumoniae in a child with systemic lupus erythematosus. Acta Paediatr Taiwan 43 (2002) 291-294
77. Kraus A., Cabral A.R., Sifuentes-Osornio J., et al. Listeriosis in patients with connective tissue diseases. J Rheumatol 21 (1994) 635-638
78. Abramson S., Kramer S.B., Radin A., et al. Salmonella bacteremia in systemic lupus erythematosus. Eight year experience at a municipal hospital. Arthritis Rheum 28 (1985) 75-79
79. Chen Y.H., Chen T.P., Lu P.L., et al. Salmonella choleraesuis bacteremia in southern Taiwan. Kaohsiung J Med Sci 15 (1999) 202-208
80. Kraus A., Guerra-Bautista G., and Alarcón-Segovia D. Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. J Rheumatol 18 (1991) 1328-1331
81. Mc-Nab P., Fuentealba C., Ballesteros F., et al. Nocardia asteroides infection in a patient with systemic lupus erythematosus. [Infección por Nocardia asteroides en un paciente con lupus eritematoso sistémico]. Rev Med Chil 128 (2000) 526-528
82. Tsao C.H., Chen C.Y., Ou L.S., et al. Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol 29 (2002) 1214-1218
83. Wang T.K., Ho P.L., and Wong S.S. Recurrent bacteraemia caused by different Salmonella species in a systemic lupus erythematosus patient. New Microbiol 28 (2005) 151-156
84. Joshua F., Riordan J., and Sturgess A. Salmonella typhimurium mediastinal abscess in a patient with systemic lupus erythematosus. Lupus 12 (2003) 710-713
85. Betrosian A.P., Balla M., Papanikolaou M., et al. Meningococcal purpura fulminans in a patient with systemic lupus erythematosus: a mimic for catastrophic antiphospholipid antibody syndrome?. Am J Med Sci 327 (2004) 373-375
86. Oztekin K., Akercan F., Yucebilgin M.S., et al. Pelvic actinomycosis in a postmenopausal patient with systemic lupus erythematosus mimicking ovarian malignancy: case report and review of the literature. Clin Exp Obstet Gynecol 31 (2004) 154-157
87. Mok C.C., Yuen K.Y., and Lau C.S. Nocardiosis in systemic lupus erythematosus. Sem Arthritis Rheum 26 (1997) 675-683
88. Pelayes D.E., Colombero D., Gioino J.M., et al. [Endogenous Nocardia asteroides endophthalmitis in a patient with systemic lupus erythematosus]. Medicina (B Aires) 64 (2004) 146-148
89. Victorio-Navarra S.T., Dy E.E., Arroyo C.G., et al. Tuberculosis among Filipino patients with systemic lupus erythematosus. Sem Arthritis Rheum 26 (1996) 628-634
90. Duzgun N., Peksari Y., Sonel B., et al. Localization of extrapulmonary tuberculosis in the synovial membrane, skin, and meninges in a patient with systemic lupus erythematosus and IgG deficiency. Rheumatol Int 22 (2002) 41-44
91. Hoffman G.S., Myers R.L., Stark F.R., et al. Septic arthritis associated with mycobacterium avium: a case report and literature review. J Rheumatol 5 (1978) 199-209
92. Zvetina J.R., Demos T.C., and Rubinstein H. Mycobacterium intracellulare infection of the shoulder and spine in a patient with steroid-treated systemic lupus erythematosus. Skeletal Radiol 8 (1982) 111-113
93. Hsu P.Y., Yang Y.H., Hsiao C.H., et al. Mycobacterium kansasii infection presenting as cellulitis in a patient with systemic lupus erythematosus. J Formos Med Assoc 101 (2002) 581-584
94. Yang W.K., Fu L.S., Lan J.L., et al. Mycobacterium avium complex-associated hemophagocytic syndrome in systemic lupus erythematosus patient: report of one case. Lupus 12 (2003) 312-316
95. Kahl L.E. Herpes zoster infections in systemic lupus erythematosus: Risk factors and outcome. J Rheumatol 21 (1994) 84-86
96. Bang S., Park Y.B., Kang B.S., et al. CMV enteritis causing ileal perforation in underlying lupus enteritis. Clin Rheumatol 23 (2004) 69-72
97. Tokunaga N., Sadahiro S., Kise Y., et al. Gastrointestinal cytomegalovirus infection in collagen diseases. Tokai J Exp Clin Med 28 (2003) 35-38
98. Ohashi N., Isozaki T., Shirakawa K., et al. Cytomegalovirus colitis following immunosuppressive therapy for lupus peritonitis and lupus nephritis. Intern Med 42 (2003) 362-366
99. Drevlow B.E., Schilling E.M., Khabbaz R.F., et al. Retroviral risk factors in patients with autoimmune disease. J Rheumatol 23 (1996) 428-431
100. Hazarika I., Chakravarty B.P., Dutta S., et al. Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide. Clin Rheumatol 25 (2006) 98-100
101. Wanchu A., Sud A., Singh S., et al. Human immunodeficiency virus infection in a patient with systemic lupus erythematosus. J Assoc Physicians India 51 (2003) 1102-1104
102. Kopelman R.G., and Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 84 (1988) 82-88
103. Chowdhry I.A., Tan I.J., Mian N., et al. Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection. J Rheumatol 32 (2005) 1365-1368
104. Hsu T.-C., and Tsay G.J. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatol 40 (2001) 152-157
105. Godeau B., Coutant-Perronne V., Le Thi Huong D., et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21 (1994) 246-251
106. Kadoya A., Okada J., Iikuni Y., et al. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 23 (1996) 1186-1188
107. Liam C.K., and Wang F. Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus. Lupus 1 (1992) 379-385
108. Porges A.J., Beattie S.L., Ritchlin C., et al. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol 19 (1992) 1191-1194
109. Wainstein E., Neira O., and Guzman L. Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia. [Lupus eritematoso diseminado y pneumonía a Pneumocystis carinii]. Rev Med Chil 121 (1993) 1422-1425
110. Li J., Huang X.M., Fang W.G., et al. Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 12 (2006) 114-117
111. Werlinger K.D., and Yen M.A. Eumycotic mycetoma caused by Cladophialophora bantiana in a patient with systemic lupus erythematosus. J Am Acad Dermatol 52 (2005) S114-S117
112. Katz A., Ehrenfeld M., Livneh A., et al. Aspergillosis in systemic lupus erythematosus. Sem Arthritis Rheum 26 (1996) 635-640
113. Canova E.G., Rosa D.C., Vallada M.G., et al. Invasive aspergillosis in juvenile systemic lupus erythematosus. A clinico-pathologic case. Clin Exp Rheumatol 20 (2002) 736
114. Setoyama M., Fukumaru S., Takasaki T., et al. SLE with death from acute massive pulmonary hemorrhage cause by disseminated strongyloidiasis. Scand J Rheumatol 26 (1997) 389-391
115. Braun J., Sieper J., Schulte K.L., et al. Visceral leishmaniasis mimicking a flare of systemic lupus erythematosus. Clin Rheumatol 10 (1991) 445-448
116. dos Santos-Neto L.L., Polcheira M.F., Castro C., et al. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus]. Rev Soc Bras Med Trop 36 (2003) 613-615
117. Deleze M., Mintz G., and del Carmen Mejia M. Toxoplasma gondii encephalitis in systemic lupus erythematosus. A neglected cause of treatable nervous system infection. J Rheumatol 12 (1985) 994-996
118. Domenech E., and Kelly J. Swallowing disorders. Med Clin North Am 83 (1999) 97-113
119. Mitchell H., Bolster M.B., and Leroy E.C. Scleroderma and related conditions. Med Clin North Am 81 (1997) 129-149
120. Rajapakse C.N., Bancewicz J., Jones C.J., et al. Pharyngo-oesophageal dysphagia in systemic sclerosis. Ann Rheum Dis 40 (1981) 612-614
121. Rosas V., Conte J.V., Yang S.C., et al. Lung transplantation and systemic sclerosis. Ann Transplant 5 (2000) 38-43
122. De Santis M., Bosello S., La Torre G., et al. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis. Respir Res 6 (2005) 96
123. Pando J., and Nashel D.J. Clinical images: progressive calcifications and draining lesions following staphylococcal infection in a patient with limited scleroderma. Arthritis Rheum 41 (1998) 373
124. Binks M., Passweg J.R., Furst D., et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 60 (2001) 577-584
125. Silver R.M., Warrick J.H., Kinsella M.B., et al. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (Scleroderma) with interstitial lung disease. J Rheumatol 20 (1993) 838-844
126. Seibold J.R., Korn J.H., Simms R., et al. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 132 (2000) 871-879
127. Ferri C., Valentini G., Cozzi F., et al. Systemic sclerosis. Demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 81 (2002) 139-153
128. Scussel-Lonzetti L., Joyal F., Raynauld J.P., et al. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 81 (2002) 154-167
129. Pirila L., Soderstrom K.O., Hietarinta M., et al. Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma. J Clin Microbiol 44 (2006) 2295-2297
130. Nishioka K., Katayama I., Kondo H., et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 23 (1996) 677-682
131. Minor Jr. R.L., Baum S., and Schulze-Delrieu K.S. Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature. Arch Intern Med 148 (1988) 1453-1455
132. Pialoux G., Mouly F., Cadranel J.F., et al. Infection of ascitic fluid by perforation of a sclerodermic colon. [Infection d'ascite par perforation sur colon sclerodermique]. Gastroenterol Clin Bio 16 (1992) 705-707
133. Walz B.H., and Crosby L.A. Mycobacterium avium-intracellulare infection of the knee joint. Case report. Am J Knee Surg 8 (1995) 35-37
134. Gerster J.C., Duvoisin B., Dudler J., et al. Tenosynovitis of the hands caused by mycobacterium kansasii in a patient with scleroderma. J Rheumatol 31 (2004) 2523-2525
135. Ferry A.P., Font R.L., Weinberg R.S., et al. Nocardial endophthalmitis: report of two cases studied histopathologically. Br J Ophthal 72 (1988) 55-61
136. Yazawa N., Fujimoto M., Kikuchi K., et al. High seroprevalence of helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 27 (2000) 1568-1569
137. Dziadzio M., Giovagnoni A., Pomponio G., et al. Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin Rheumatol 22 (2003) 487-490
138. Kahaleh M.B., and Leroy E.C. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 31 (1999) 195-214
139. Longo F., Saletta S., Lepore L., et al. Localized scleroderma after infection with Epstein-Barr virus. Clin Exp Rheumatol 11 (1993) 681-683
140. Ferri C., Zakrzewska K., Longombardo G., et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 17 (1999) 718-720
141. Ward M.M., and Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42 (1999) 780-789
142. Zamost B.J., Hirschberg J., Ippoliti A.F., et al. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterol 92 (1987) 421-428
143. Kovacs S.O., and Kovacs S.C. Dermatomyositis. J Am Acad Dermatol 39 (1998) 899-921
144. Schwarz M.I. Thoracic manifestations of the systemic autoimmune diseases. The lung in polymyositis. Clin Chest Med 19 (1998) 701-712
145. Bahner D., Meller J., Stiefel M., et al. Juvenile dermatomyositis-acute recidivism or sepsis. [Juvenile dermatomyositis-akutes Rezidiv oder Sepsis]. Nervenarzt 70 (1999) 547-551
146. Eisenstein D., Paller A.S., and Pachman L.M. Juvenile dermatomyositis. Pediatrics 103 (1999) 195
147. Moore E.C., Cohen F., Douglas S.D., et al. Staphylococcal infections in childhood dermatomyositis-association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. Ann Rheum Dis 51 (1992) 378-383
148. Kanik K.S., and Cash J.M. Methotrexate. Does methotrexate increase the risk of infection or malignancy?. Rheum Dis Clin North Am 23 (1997) 955-967
149. Klein-Gitelman M.S., and Szer I.S. Disseminated nocardia brasiliensis infection: an unusual complication of immunosuppressive treatment for childhood dermatomyositis. J Rheumatol 18 (1991) 1243-1246
150. Xue L., Chen X., and Chen S. Prognostic factors of dermatomyositis: analysis of 119 cases. [Chinese]. Zhonghua Nei Ke Za Zhi 36 (1997) 32-35
151. Amano K., Maruyama H., Mori S., et al. [Respiratory failure in polymyositis and dermatomyositis: differential diagnosis between pulmonary infection and interstitial pneumonitis]. [Japanese]. Kansenshogaku Zasshi 72 (1998) 517-525
152. Casademont J., Roger N., Pedrol E., et al. Streptococcal myositis as a complication of juvenile dermatomyositis. Neuromuscular Disor 1 (1991) 375-377
153. Soriano E.R., Barcan L., Clara L., et al. Streptococcus pyomyositis occurring in a patient with dermatomyositis in a country with temperate climate. J Rheumatol 19 (1992) 1305-1307
154. Marie I., Herve F., Kerleau J.M., et al. Helicobacter heilmanii gastritis in polymyositis. Eur J Intern Med 17 (2006) 213-214
155. Marie I., Hachulla E., Cherin P., et al. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53 (2005) 155-165
156. Kofteridis D., Mantadakis E., Mixaki I., et al. Primary cutaneous nocardiosis in 2 patients on immunosuppressants. Scand J Infect Dis 37 (2005) 507-510
157. Hernandez-Cruz B., Cardiel M.H., Villa A.R., et al. Development, recurrence, and severity of infections in Mexican patients with RA: a nested case-control study. J Rheumatol 25 (1999) 1900-1907
158. Schaller M., Korting H.C., Meurer M., et al. Generalized mycobacterium avium-intracellulare infection due to immunosuppressive therapy of paraneoplastic dermatomyositis. [Generalisierte mycobacterium avium-intracellulare infektion immun suppressiver therapie einer paraneoplastischer dermatomyositis]. Hautarzt 48 (1997) 118-121
159. Nagaoka S., Tani K., Ishigatsubo Y., et al. [Herpes zoster in patients with polymyositis and dermatomyositis]. [Japanese]. Kansenshogaku Zasshi 64 (1990) 1394-1399
160. Nishi K., Myoh S., Bandoh T., et al. [An autopsy case of dermatomyositis associated with interstitial pneumonia probably due to cytomegalovirus infection]. [Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 30 (1992) 1975-1980
161. Yoshihara S., Fukuma N., and Masago R. [Cytomegalovirus infection associated with immunosuppressive therapy in collagen vascular diseases]. [Japanese]. Ryumachi 39 (1999) 740-748
162. Yoda Y., Hanaoka R., Ide H., et al. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia. Mod Rheumatol 16 (2006) 137-142
163. Kasifoglu T., Korkmaz C., and Ozkan R. Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis. Clin Rheumatol 25 (2006) 731-733
164. Crowson A.N., Magro C.M., and Dawood M.R. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 27 (2000) 505-515
165. Fiore G., Giacovazzo F., and Giacovazzo M. HCV and dermatomyositis: report of 5 cases of dermatomyositis in patients with HCV infection. Riv Eur Sci Med Farmacol 18 (1996) 197-201
166. Lewkonia R.M., Horne D., and Dawood M.R. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 21 (1995) 430-432
167. Bachelez H., Schremmer B., Cadranel J., et al. Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis (Clinical observation). Arch Intern Med 157 (1997) 1501-1503
168. Henseler T. [Mucocutaneous candidiasis in patients with skin diseases]. [German]. Mycoses 1 (1995) 7-13
169. Voloshin D.K., Lacomis D., and McMahon D. Disseminated histoplasmosis presenting as myositis and fasciitis in a patient with dermatomyositis. Muscle Nerve 18 (1995) 531-535
170. Ward M.M., Pyun E., and Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 38 (1995) 274-283
171. Jacobsen S., Petersen J., Ullman S., et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 17 (1998) 468-477
172. Petri M. Musculoskeletal complications of systemidc lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8 (1995) 137-145
173. Abu-Shakra M., Urowitz M.B., Gladman D.D., et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22 (1995) 1259-1264
174. Wongchinsri J., Tantawichien T., Osiri M., et al. Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients. J Med Assoc Thai 85 Suppl 1 (2002) S34-S39
175. Pope J.E., Krizova A., Ouimet J.M., et al. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. J Rheumatol 31 (2004) 274-279